Table 1

Demographic and Clinical Data

Control (n = 33)Dopamine (n = 33)p Value
Age (yrs)59.9 ± 1.762.9 ± 1.2NS
Female6/33 (18%)9/33 (27%)NS
Weight71.8 ± 2.775.5 ± 2.3NS
Amount of contrast material used (ml)163.2 ± 13.2173.8 ± 13.0NS
Urine volume (per day) during study protocol1979 ± 1742106 ± 158NS
Serum Cr level before angiography (μmol/liter)100.6 ± 5.2100.3 ± 5.4NS
Chronic renal failure6/33 (18%)8/33 (24%)NS
Previous exposure to contrast agents18/33 (54%)16/33 (48%)NS
Previous radiocontrast nephropathy2/33 (6%)1/33 (3%)NS
Diabetes mellitus (DM)28 (79%)30 (91%)NS
 Diabetic nephropathy: Proteinuria9/24 (37.5%)13/20 (65%)NS
History of hypertension14/33 (42%)22/33 (67%)NS
 Systolic BP on admission131.4 ± 3.9141.5 ± 4.9NS
 Diastolic BP on admission75.7 ± 1.779.1 ± 2.7NS
Hyperlipidemia16/33 (48%)16/33 (48%)NS
Smoking14/33 (42.4%)14/33 (42.4%)NS
Ischemic heart disease30/33 (90%)30/33 (90%)NS
Congestive heart failure9/33 (27%)12/33 (36%)NS
Moderate-poor left ventricular function17/26 (65%)13/26 (50%)NS
Peripheral vascular disease7/33 (21%)11/33 (33%)NS